UB Paderborn / Katalog / Suche / in CDI

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

Journal of thrombosis and haemostasis, 2006-03, Vol.4 (3), p.542-549

2006

Volltextzugriff (PDF)

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

Journal of thrombosis and haemostasis, 2003-07, Vol.1 (7), p.1575-1579

2003

Volltextzugriff (PDF)

Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study

Circulation (New York, N.Y.), 2004-03, Vol.109 (11), p.1343-1348

2004

Volltextzugriff (PDF)

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Arteriosclerosis, thrombosis, and vascular biology, 2002-05, Vol.22 (5), p.867

2002

Volltextzugriff (PDF)

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study

Arteriosclerosis, thrombosis, and vascular biology, 2007-10, Vol.27 (10), p.2250

2007

Volltextzugriff (PDF)

Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism

Value in health, 2014-11, Vol.17 (7), p.A488-A488

2014

Volltextzugriff (PDF)

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

Journal of thrombosis and haemostasis, 2010-05, Vol.8 (5), p.942-949

2010

Volltextzugriff (PDF)

TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study

Journal of thrombosis and haemostasis, 2005-07, Vol.3 (7), p.1503-1510

2005

Volltextzugriff (PDF)

OP9: Diet modulates endogenous thrombin generation, a biological estimate of thrombosis risk, independently of the metabolic status

Diabetes & metabolism, 2012-11, Vol.38, p.S101-S101

2012

Volltextzugriff (PDF)

O1 Facteurs prédictifs de la résistance au clopidogrel à 1 mois du syndrome coronarien aigu chez le patient diabétique

Diabetes & metabolism, 2012-03, Vol.38, p.A1-A1

2012

Volltextzugriff (PDF)

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia

Chest, 2021-06, Vol.159 (6), p.2417-2427

2021

Volltextzugriff (PDF)

The missing heritability of venous thrombosis: what about factor V Leiden heterogeneity?

Journal of thrombosis and haemostasis, 2018-11, Vol.16 (11), p.2125-2127

2018

Volltextzugriff (PDF)

Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study

Atherosclerosis, 2005-04, Vol.179 (2), p.317-323

2005

Volltextzugriff (PDF)

P127 L’équilibre glycémique est-il impliqué dans la non réponse aux antiagrégants du sujet diabétique ?

Diabetes & metabolism, 2009, Vol.35, p.A58-A58

2009

Volltextzugriff (PDF)

O81 Contribution de la glycémie et de la résistance à l’insuline à la réponse au clopidogrel en phase aiguë du syndrome coronarien non ST

Diabetes & metabolism, 2009, Vol.35, p.A21-A21

2009

Volltextzugriff (PDF)

Lessons from genome‐wide association studies in venous thrombosis

Journal of thrombosis and haemostasis, 2011-07, Vol.9, p.258-264

2011

Volltextzugriff (PDF)

α1‐antitrypsin Pittsburgh and plasmin‐mediated proteolysis

Journal of thrombosis and haemostasis, 2016-10, Vol.14 (10), p.2023-2026

2016

Volltextzugriff (PDF)

Diagnosis and management of heparin-induced thrombocytopenia

Anaesthesia critical care & pain medicine, 2020-04, Vol.39 (2), p.291-310

2020

Volltextzugriff (PDF)

Is there still room for additional common susceptibility alleles for venous thromboembolism?

Journal of thrombosis and haemostasis, 2016-09, Vol.14 (9), p.1798-1802

2016

Volltextzugriff (PDF)

Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

Arteriosclerosis, thrombosis, and vascular biology, 2006-12, Vol.26 (12), p.2793

2006

Volltextzugriff (PDF)

Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)

Anaesthesia critical care & pain medicine, 2021-08, Vol.40 (4), p.100919-100919

2021

Volltextzugriff (PDF)

Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles‐NImes prediction model

Journal of thrombosis and haemostasis, 2014-02, Vol.12 (2), p.138-146

2014

Volltextzugriff (PDF)

Protein S inherited qualitative deficiency: novel mutations and phenotypic influence

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2718-2726

2010

Volltextzugriff (PDF)

Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study

Metabolism, clinical and experimental, 2004-07, Vol.53 (7), p.852-857

2004

Volltextzugriff (PDF)

Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

Journal of thrombosis and haemostasis, 2009-01, Vol.7 (1), p.49-57

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study

Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study

OP9: Diet modulates endogenous thrombin generation, a biological estimate of thrombosis risk, independently of the metabolic status

O1 Facteurs prédictifs de la résistance au clopidogrel à 1 mois du syndrome coronarien aigu chez le patient diabétique

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia

The missing heritability of venous thrombosis: what about factor V Leiden heterogeneity?

Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study

P127 L’équilibre glycémique est-il impliqué dans la non réponse aux antiagrégants du sujet diabétique ?

O81 Contribution de la glycémie et de la résistance à l’insuline à la réponse au clopidogrel en phase aiguë du syndrome coronarien non ST

Lessons from genome‐wide association studies in venous thrombosis

α1‐antitrypsin Pittsburgh and plasmin‐mediated proteolysis

Diagnosis and management of heparin-induced thrombocytopenia

Is there still room for additional common susceptibility alleles for venous thromboembolism?

Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles‐NImes prediction model

Protein S inherited qualitative deficiency: novel mutations and phenotypic influence

Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study

Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

Suchergebnisse filtern